Inflammatory Bowel DiseaseJoseph B. Kirsner World-renowned experts present state-of-the-art information in the clinical understanding of inflammatory bowel disease in the 5th Edition of this best-selling text. Scholarly and pragmatic, this text features authoritative information on the medical and surgical management of IBD with the support of over 390 illustrations. Features many new chapters, including those covering intestinal permeability in health and disease, the intestinal response to acute inflammation and injuries, and current concepts of IBD etiology and pathogenesis. |
From inside the book
Results 1-3 of 69
Page 537
... therapy ( see later discussion ) . Some formulations , including beclomethasone94 and budes- onide ( personal data ) , can be combined with me- salamine as an enema or suppository to improve the response to individual therapy . Moderate ...
... therapy ( see later discussion ) . Some formulations , including beclomethasone94 and budes- onide ( personal data ) , can be combined with me- salamine as an enema or suppository to improve the response to individual therapy . Moderate ...
Page 540
... therapy in UC . If patients continue to develop flare - ups despite maintenance therapy with aminosalicylates or azathioprine / 6- mercaptopurine , a colectomy should be considered . Methotrexate There is limited evidence to support the ...
... therapy in UC . If patients continue to develop flare - ups despite maintenance therapy with aminosalicylates or azathioprine / 6- mercaptopurine , a colectomy should be considered . Methotrexate There is limited evidence to support the ...
Page 544
... therapy and patient preference . Patients who have responded to rectal mesalamine are more likely to remain in remission with continuation of topical therapy than by transferring to oral treatment , 218 and combining oral and topical ...
... therapy and patient preference . Patients who have responded to rectal mesalamine are more likely to remain in remission with continuation of topical therapy than by transferring to oral treatment , 218 and combining oral and topical ...
Common terms and phrases
acid activity acute addition adhesion agents altered animals antibodies antigen appears associated bacterial barrier cause changes chronic Clin clinical colonic common complex Crohn's disease cytokines defect demonstrated develop effect enhanced enteric epithelial cells epithelium et al evidence experimental expression factor function Gastroenterol Gastroenterology gene genetic growth factor human immune Immunol important incidence increased induced infection inflammation inflammatory bowel disease inhibition initial injury interactions intestinal epithelial cells involved lamina propria levels lymphocytes lymphoid macrophages major mechanisms mediators mice molecules mucosal muscle neutrophils normal observed occurs oral patients permeability Peyer's patches population present produced protective protein rates rats recent receptor region regulation relatives reported response risk role secretion severe showed shown similar small intestine smoking specific stimulation studies suggest surface T-cell Table tion tissue tolerance treatment ulcerative colitis